RRAD was significantly expressed at a lower level in LNSCs of RA patients (p = 0.037), whereas GAD1 was highly expressed in LNSCs of RA-risk individuals (p = 0.0129) when compared to healthy individuals (Figure 3B). Here, GAD1 is linked to rheumatoid arthritis.